Quantus

AI platform to generate, adapt, and consolidate value evidence—craft value messages, train teams, and measure impact.

[Quantus @GetQuantus]

Local strategy or just a translated deck?

The payer evaluates their budget, their patients, and their risks — not the international average.

Translating ≠ localizing.
DM me LOCAL 👇

#MarketAccess #Quantus #LocalStrategy #HTA

[Quantus @GetQuantus]

The WHO 3x GDP per capita threshold is dead.

The WHO said so. Lancet Global Health confirmed it: 97% of countries sit below 1x GDP per QALY.

Brazil, Colombia and Peru already set their own. Is your dossier keeping up?

Country map for LATAM 👇 https://t.co/afvnK5Q5Hg

[Quantus @GetQuantus]

Does your team know how to use AI but not understand the process? That's called de-skilling.

Overreliance erodes critical thinking — and in healthcare, that's a real risk.

Comment BALANCE 👇 and I'll show you how to avoid it.

#AI #Healthcare #Pharma #Leadership

[Quantus @GetQuantus]

In LATAM pharma, pricing is never just pricing.

One decision can affect access, margins, and negotiations across multiple countries.

The smartest teams model regional impact before launch.

👇 Full blog here: https://t.co/fWQp1hBoM3

#Pharma #Pricing #MarketAccess #LATAM

[Quantus @GetQuantus]

Evidence alone doesn’t win access.

HTA frameworks define how decisions are really made.

Teams that understand that logic build stronger dossiers and reduce friction with payers.

👇 Full blog here: https://t.co/hb7l0qLGRF

#Pharma #HTA #MarketAccess #HEOR

[Quantus @GetQuantus]

AI is changing pharma faster than most teams realize.

Some companies are still testing.

Others are already transforming market access workflows.

The gap is growing.

👇 Full blog here: https://t.co/xit4T7C5H9

#Pharma #AI #MarketAccess #HTA

[Quantus @GetQuantus]

6 months of work.

4 minutes to read.

A “no.”

The problem isn’t your dossier.

It’s not answering:

👉 cost or savings?

💬 DM VALUE to see how to close with evidence.

#Pharma #MarketAccess #Healthcare

[Quantus @GetQuantus]

AI is already transforming pharma.

Now the regulations are coming.

🇪🇺 EU AI Act
🇺🇸 FDA draft guidance
⚠️ And still a lot of uncertainty.

👇 Comment COMPLY

#Pharma #AI #Regulation #MarketAccess

[Quantus @GetQuantus]

AI isn’t the advantage anymore.

Execution is.

Some teams are moving faster.

Others are still catching up.

The gap is real.

👇 Full blog here https://t.co/NYJrOcJSRv

#Pharma #AI #MarketAccess #HTA

[Quantus @GetQuantus]

You have data.
You have evidence.

And still no decision.

It’s not the product.
It’s the story.

👉 Swipe
📩 DM VALUE STORY

#Pharma #MarketAccess #HEOR #HTA

[Quantus @GetQuantus]

You won the tender with AI…

But the market?

⬇️ -30% prices
⬇️ Margins
⬆️ Risk

Winning isn’t always winning.

👇 Comment VALUE

#Pharma #MarketAccess #AI #Pricing

[Quantus @GetQuantus]

You present evidence.

They say: “we’ll review it.”

And nothing happens.

It’s not interest.

It’s relevance.

👉 Swipe

📩 DM VALUE

#Pharma #MarketAccess #HEOR #HTA

[Quantus @GetQuantus]

3 HTA agencies in LATAM.

0 clear AI rules.

But dossiers with AI are already arriving.

The advantage will go to teams that use AI with

traceability, validation, and rigor.

👇 Read the full blog here: https://t.co/n4HE9SD6gh

#Pharma #MarketAccess #HEOR #AIinHealthcare #HTA

[Quantus @GetQuantus]

CONITEC and IETS still have no clear AI guidance for HTA evidence.

That’s not a pause.

It’s a window to set the benchmark.

The teams that document rigor today will lead tomorrow.

👇Read the full blog here: https://t.co/dj645ld7lx

#Pharma #MarketAccess #HEOR #AIinHealthcare

[Quantus @GetQuantus]

Your product isn’t expensive.

You’re telling the wrong story.

Payers care about disease cost, not price.

👉 Swipe
📩 DM REAL COST

#Pharma #MarketAccess #HEOR #HTA

[Quantus @GetQuantus]

$15K in training…

80% forgotten in weeks

❌ Not your team
❌ Your training model

🚀 No practice = no performance

📩 DM: MASTERY

[Quantus @GetQuantus]

Most pharma teams still spend 4–8 months building a GVD.

AI is cutting that to weeks.

Same rigor.
Faster payer readiness.

👇 Read the full blog here---> https://t.co/5t0tSE6wgk

#Pharma #MarketAccess #HEOR #AIinHealthcare #HTA

[Quantus @GetQuantus]

A Global Value Dossier no longer needs 4–8 months.

AI is already turning months into weeks—with the same methodological rigor.

The real edge?
Getting to HTA windows first.

👇 Read the full blog here--> https://t.co/a4BALKHy4y

#Pharma #MarketAccess #HEOR #AI #HTA #GVD

[Quantus @GetQuantus]

You’re not losing because of the product.

You’re losing because of the message.

💡 Payers think budget, not studies

🚀 Change the conversation

📩 DM: PRECISION

[Quantus @GetQuantus]

Brazil is now the toughest HTA market in LATAM.

CONITEC + real-world data + AI

= new rules for access.

It’s not about better products.

It’s about better evidence, faster.

👇 Link to read the blog https://t.co/JXAFekSKDm

#Pharma #MarketAccess #HEOR #AIinHealthcare #HTA